AI Convergence: Small Molecule Discovery Summit
📅 Wednesday, 24 March 2027 → Thursday, 25 March 2027 in 250 days
Boston summit on AI and machine learning for small-molecule drug discovery and design.
The AI Convergence: Small Molecule Discovery Summit returns to Boston on 24 and 25 March 2027. It is a focused industry summit on the use of artificial intelligence and machine learning in small-molecule drug discovery, gathering computational and medicinal chemists working to accelerate the earliest stages of the pipeline.
The programme concentrates on AI and ML methods for hard problems in small-molecule design — approaching traditionally undruggable targets, structure- and ligand-based design, and integrating predictive models such as protein-structure prediction into discovery workflows. It is aimed at drug-discovery scientists, computational chemists and cheminformatics teams in biotech and pharma.
The 2027 speaker line-up and detailed agenda build on a substantial 2026 edition; treat prior-year names as provisional until the 2027 programme is confirmed. Registration and current pricing are handled through the official summit site, where the finalised agenda will be published closer to the date.
